DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Semuloparin sodium
Semuloparin sodium
Modifications to the Harmonized Tariff Schedule of the United States to Implement Changes to the Pharmaceutical Appendix
Primary Prophylaxis for Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy (Review) I Copyright © 2016 the Cochrane Collaboration
WHO Drug Information Vol 23, No
Primary Prophylaxis for Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy (Review)
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
INN Working Document 05.179 Update December 2010
Pharmacological Effects and Clinical Applications of Ultra Low Molecular Weight Heparins
(INN) for Biological and Biotechnological Substances
Newer Oral Anticoagulant Therapy – Prospects and Practices: a Review
FDA Briefing Document Oncologic Drugs Advisory Committee Meeting June 20, 2012
Primary Prophylaxis for Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy (Review)
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Pharmaabkommen A1 E
INN Working Document 05.179 Distr.: GENERAL ENGLISH ONLY 08/11/2009
Valstybinės Vaistų Kontrolės Tarnybos Prie Lietuvos Respublikos Sveikatos Apsaugos Ministerijos Viršininko Įsakymas
(12) United States Patent (10) Patent No.: US 9,707,155 B2 Weeks Et Al
Use of Heparins in Patients with Cancer: Individual Participant Data Meta- Analysis of Randomised Trials Study Protocol
Top View
Regulation (EU) No 1238/2010 of the European Parliament
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Primary Prophylaxis for Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy (Review)
Potential Role of New Anticoagulants for Prevention and Treatment of Venous Thromboembolism in Cancer Patients
Synopsis 27-Jun-2011 AVE5026 / EFC6521 - Semuloparin Sodium Version Number : 1 (Electronic 1.0)
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
( 12 ) United States Patent
Cq 16-2 敗血症における深部静脈血栓症の予防として抗凝固療法(未分画ヘパリン、低分 子ヘパリン、ワーファリン、Noac/Doac)を行うか?
Annexes to the European Medicines Agency's 2012 Annual Report
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri